Overview

First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation

Status:
Completed
Trial end date:
2018-01-18
Target enrollment:
Participant gender:
Summary
This is a phase 1 safety study performed in male or female adult participants with an established diagnosis of severe to profound sensorineural hearing loss that meets the criteria for cochlear implantation and the participant has already chosen to undergo cochlear implant surgery.
Phase:
Early Phase 1
Details
Lead Sponsor:
Frequency Therapeutics